Biotech Manufacturing Companies in Nevada

Nevada has approximately 1,600 manufacturing establishments and 48,000 manufacturing employees. Nevada's manufacturing sector is rapidly growing, led by Tesla's Gigafactory near Reno, Panasonic's battery production, and expanding logistics-adjacent manufacturing.

Nevada contributes to the national biotech manufacturing landscape. Biotech manufacturing encompasses the production of biologic drugs including monoclonal antibodies, cell and gene therapies, vaccines, and recombinant proteins. Unlike traditional pharmaceutical manufacturing, biotech production relies on living cell systems and requires specialized bioprocessing equipment, single-use systems, and advanced purification technologies.

Monoclonal Antibody Producers: Companies operating large-scale mammalian cell culture facilities for antibody drug production.

Cell Therapy Manufacturers: Facilities producing autologous and allogeneic cell therapies including CAR-T and stem cell products.

Gene Therapy Producers: Companies manufacturing viral vectors (AAV, lentivirus) for gene therapy applications.

Vaccine Manufacturers: Facilities producing vaccines using traditional and mRNA platforms, including fill-finish operations.

Contract Biologics Manufacturers: CDMOs specializing in biologic drug manufacturing, from cell line development through commercial production.

Major industrial centers in Nevada include Las Vegas, Reno, Sparks, and Henderson. These cities have concentrations of manufacturers across sectors including ev manufacturing, food processing manufacturing, and aerospace manufacturing.